Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Infectious Diseases

Background:

• The COVID-19 pandemic highlighted the significant association between obesity and increased disease severity.
• Obesity is characterized by chronic inflammation and metabolic alterations, contributing to various health complications.

Purpose of the Study:

• To elucidate the multifaceted mechanisms linking obesity to severe COVID-19 outcomes.
• To explore the roles of inflammation, adipokines, and endothelial dysfunction in COVID-19 severity among obese individuals.

Main Methods:

• Review of existing literature on obesity, inflammation, and COVID-19 pathophysiology.
• Analysis of the impact of adipokines (leptin, resistin) on vascular adhesion molecules.
• Examination of endothelial function impairment in obese patients infected with SARS-CoV-2.

Main Results:

• Obesity-related inflammation involves elevated cytokines and deregulated adipokines, increasing vascular adhesion.
• Impaired endothelial function in obese individuals is worsened by SARS-CoV-2 infection, leading to poor outcomes.
• Obesity's prothrombotic state and cardiac alterations contribute to increased cardiovascular events in COVID-19 patients.

Conclusions:

• Obesity significantly increases COVID-19 severity through interconnected inflammatory and vascular pathways.
• Targeting inflammation and improving endothelial function may be key strategies for managing severe COVID-19 in obese populations.
• Further research into the complex interplay between metabolic health and viral infections is warranted.